Fátima Ferreira

Fátima Ferreira

Christian Doppler Laboratory for Allergy Diagnosis and Therapy, University of Salzburg

Affiliated withUniversity of Salzburg

Research Area

Biography

Fátima Ferreira has not added Biography.
If you are Fátima Ferreira and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
Publication title

Cited by 14

2011

Other Publications

Article
Year
Genetic engineering of allergens: future therapeutic products.

International archives of allergy and immunology| PubMed ID: 12119498

Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 12475905

2003
IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone.

The Journal of allergy and clinical immunology| PubMed ID: 12704373

2003
2004
Customized antigens for desensitizing allergic patients.

Advances in immunology| PubMed ID: 15246251

Biology of weed pollen allergens.

Current allergy and asthma reports| PubMed ID: 15283880

2004
The spectrum of allergens in ragweed and mugwort pollen.

International archives of allergy and immunology| PubMed ID: 16254437

Is genetic vaccination against allergy possible?

International archives of allergy and immunology| PubMed ID: 16534215

Modified recombinant allergens for safer immunotherapy.

Inflammation & allergy drug targets| PubMed ID: 16613559

Calcium-binding proteins and their role in allergic diseases.

Immunology and allergy clinics of North America| PubMed ID: 17276877

Specific immunotherapy in pollen allergy.

Current opinion in molecular therapeutics| PubMed ID: 17458170

Allergy multivaccines created by DNA shuffling of tree pollen allergens.

The Journal of allergy and clinical immunology| PubMed ID: 17624416

2009
2009
Development of recombinant allergens for diagnosis and therapy.

Frontiers in bioscience (Elite edition)| PubMed ID: 19482627

2009
Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens.

The Journal of allergy and clinical immunology| PubMed ID: 19665781

2010
Antigen aggregation decides the fate of the allergic immune response.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 19995902

2010
2010
2009
Naturally processed T cell-activating peptides of the major birch pollen allergen.

The Journal of allergy and clinical immunology| PubMed ID: 20132976

Panallergens and their impact on the allergic patient.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology| PubMed ID: 20298513

2010
The role of lipid transfer proteins in allergic diseases.

Current allergy and asthma reports| PubMed ID: 20582490

Prophylactic mRNA vaccination against allergy.

Current opinion in allergy and clinical immunology| PubMed ID: 20856111

2010
Production of recombinant allergens in plants.

Phytochemistry reviews : proceedings of the Phytochemical Society of Europe| PubMed ID: 21258627

2008
2011
Reshaping the Bet v 1 fold modulates T(H) polarization.

The Journal of allergy and clinical immunology| PubMed ID: 21420160

2011
2011
Ozone affects pollen viability and NAD(P)H oxidase release from Ambrosia artemisiifolia pollen.

Environmental pollution (Barking, Essex : 1987)| PubMed ID: 21605929

Response to Detection and analysis of unusual features in the structural model and structure-factor data of a birch pollen allergen.

Acta crystallographica. Section F, Structural biology and crystallization communications| PubMed ID: 22505401

Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 23401558

The fold variant BM4 is beneficial in a therapeutic Bet v 1 mouse model.

BioMed research international| PubMed ID: 24175303

Recombinant allergens for pollen immunotherapy.

Immunotherapy| PubMed ID: 24283843

Plantago lanceolata: an important trigger of summer pollinosis with limited IgE cross-reactivity.

The Journal of allergy and clinical immunology| PubMed ID: 24698322

Molecular approach to allergy diagnosis and therapy.

Yonsei medical journal| PubMed ID: 24954310

Correlation of sensitizing capacity and T-cell recognition within the Bet v 1 family.

The Journal of allergy and clinical immunology| PubMed ID: 25670010

Advances in patent applications related to allergen immunotherapy.

Expert opinion on therapeutic patents| PubMed ID: 27011299

How relevant is panallergen sensitization in the development of allergies?

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology| PubMed ID: 27129102

Tackling Bet v 1 and associated food allergies with a single hybrid protein.

The Journal of allergy and clinical immunology| PubMed ID: 27939703

Allergens of Blomia tropicalis: An Overview of Recombinant Molecules.

International archives of allergy and immunology| PubMed ID: 28456805

Identification of Proteases and Protease Inhibitors in Allergenic and Non-Allergenic Pollen.

International journal of molecular sciences| PubMed ID: 28587253

Multi-Approach Analysis for the Identification of Proteases within Birch Pollen.

International journal of molecular sciences| PubMed ID: 28677627

Two Distinct Conformations in Bet v 2 Determine Its Proteolytic Resistance to Cathepsin S.

International journal of molecular sciences| PubMed ID: 29035299

Endolysosomal protease susceptibility of Amb a 1 as a determinant of allergenicity.

The Journal of allergy and clinical immunology| PubMed ID: 29157946

2018
Localization of Four Allergens in Artemisia Pollen by Immunofluorescent Antibodies.

International archives of allergy and immunology| PubMed ID: 30970365

Proteomic Analysis Reveals Allergen Variability among Breeds of the Dust Mite Blomia tropicalis.

International archives of allergy and immunology| PubMed ID: 31563904

A hybrid of two major Blomia tropicalis allergens as an allergy vaccine candidate.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology| PubMed ID: 32314444